These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24917361)

  • 1. Low expression of secreted frizzled-related protein 4 in aggressive pituitary adenoma.
    Wu Y; Bai J; Li Z; Wang F; Cao L; Liu C; Yu S; Yu G; Zhang Y
    Pituitary; 2015 Jun; 18(3):335-42. PubMed ID: 24917361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of sFRP4 as a bio-marker for predicting aggressiveness and recurrence of growth hormone-secreting pituitary adenomas.
    Wu Y; Liu C; Yu S; Gao H; Li Z; Li C; Zhang Y
    Oncol Rep; 2016 May; 35(5):2991-9. PubMed ID: 26935389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression of the sFRP and WIF1 genes in invasive non-functioning pituitary adenomas.
    Song W; Qian L; Jing G; Jie F; Xiaosong S; Chunhui L; Yangfang L; Guilin L; Gao H; Yazhuo Z
    Mol Cell Endocrinol; 2018 Oct; 474():168-175. PubMed ID: 29555596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-myc downstream-regulated gene 2 (NDRG2) promoter methylation and expression in pituitary adenoma.
    Vaitkiene P; Valiulyte I; Glebauskiene B; Liutkeviciene R
    Diagn Pathol; 2017 Apr; 12(1):33. PubMed ID: 28390436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-specific downregulation and methylation of the CDH13 (H-cadherin) and CDH1 (E-cadherin) genes correlate with aggressiveness of human pituitary adenomas.
    Qian ZR; Sano T; Yoshimoto K; Asa SL; Yamada S; Mizusawa N; Kudo E
    Mod Pathol; 2007 Dec; 20(12):1269-77. PubMed ID: 17873891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of DNA (Cytosine-5)-Methyltransferase 1 (DNMT1) And DNA (Cytosine-5)-Methyltransferase 3A (DNMT3A) Is Associated with Aggressive Behavior and Hypermethylation of Tumor Suppressor Genes in Human Pituitary Adenomas.
    Ma HS; Wang EL; Xu WF; Yamada S; Yoshimoto K; Qian ZR; Shi L; Liu LL; Li XH
    Med Sci Monit; 2018 Jul; 24():4841-4850. PubMed ID: 30002361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SFRP4 was overexpressed in colorectal carcinoma.
    Huang D; Yu B; Deng Y; Sheng W; Peng Z; Qin W; Du X
    J Cancer Res Clin Oncol; 2010 Mar; 136(3):395-401. PubMed ID: 19730886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a subtype-specific ENC1 gene related to invasiveness in human pituitary null cell adenoma and oncocytomas.
    Feng J; Hong L; Wu Y; Li C; Wan H; Li G; Sun Y; Yu S; Chittiboina P; Montgomery B; Zhuang Z; Zhang Y
    J Neurooncol; 2014 Sep; 119(2):307-15. PubMed ID: 24916845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demethylation of the
    Li H; Zhao J; Sun J; Tian C; Jiang Q; Ding C; Gan Q; Shu P; Wang X; Qin J; Sun Y
    Mol Cancer Res; 2021 Sep; 19(9):1454-1464. PubMed ID: 34016745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MGMT promoter methylation and immunoexpression in aggressive pituitary adenomas and carcinomas.
    Salehi F; Scheithauer BW; Kros JM; Lau Q; Fealey M; Erickson D; Kovacs K; Horvath E; Lloyd RV
    J Neurooncol; 2011 Sep; 104(3):647-57. PubMed ID: 21311951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-3 expression in pituitary adenomas as a marker of aggressive behavior.
    Righi A; Morandi L; Leonardi E; Farnedi A; Marucci G; Sisto A; Frank G; Faustini-Fustini M; Zoli M; Mazzatenta D; Agati R; Foschini MP
    Hum Pathol; 2013 Nov; 44(11):2400-9. PubMed ID: 24007691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of the p16 gene in human pituitary nonfunctioning tumors by hypermethylation is more common in null cell adenomas.
    Ruebel KH; Jin L; Zhang S; Scheithauer BW; Lloyd RV
    Endocr Pathol; 2001; 12(3):281-9. PubMed ID: 11740049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of p18(INK4C) is down-regulated in human pituitary adenomas.
    Hossain MG; Iwata T; Mizusawa N; Qian ZR; Shima SW; Okutsu T; Yamada S; Sano T; Yoshimoto K
    Endocr Pathol; 2009; 20(2):114-21. PubMed ID: 19401813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The p15(INK4b)/p16(INK4a)/RB1 pathway is frequently deregulated in human pituitary adenomas.
    Ogino A; Yoshino A; Katayama Y; Watanabe T; Ota T; Komine C; Yokoyama T; Fukushima T
    J Neuropathol Exp Neurol; 2005 May; 64(5):398-403. PubMed ID: 15892297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of DNA methylation on galectin-3 expression in pituitary tumors.
    Ruebel KH; Jin L; Qian X; Scheithauer BW; Kovacs K; Nakamura N; Zhang H; Raz A; Lloyd RV
    Cancer Res; 2005 Feb; 65(4):1136-40. PubMed ID: 15734994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human pituitary adenomas infrequently contain inactivation of retinoblastoma 1 gene and activation of cyclin dependent kinase 4 gene.
    Honda S; Tanaka-Kosugi C; Yamada S; Sano T; Matsumoto T; Itakura M; Yoshimoto K
    Endocr J; 2003 Jun; 50(3):309-18. PubMed ID: 12940460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of MGMT methylation status in pituitary adenoma.
    Arya S; Majaid MA; Shwetha SD; Sravani K; Arivazhagan A; Sampath S; Santosh V
    Pathol Res Pract; 2014 Jul; 210(7):407-11. PubMed ID: 24690322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas.
    Gong J; Zhao Y; Abdel-Fattah R; Amos S; Xiao A; Lopes MB; Hussaini IM; Laws ER
    Pituitary; 2008; 11(1):37-48. PubMed ID: 17768685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZAC1 and SSTR2 are downregulated in non-functioning pituitary adenomas but not in somatotropinomas.
    Vieria Neto L; Wildemberg LE; Colli LM; Kasuki L; Marques NV; Moraes AB; Gasparetto EL; Takiya CM; Castro M; Gadelha MR
    PLoS One; 2013; 8(10):e77406. PubMed ID: 24098585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.